Strengthening its commitment to advancing cancer care and innovation, Fortis Cancer Institute at
Fortis Hospital Mulund, Mumbai, today featured in Season 2 of the acclaimed docuseries ‘Molecules
of Hope’, on JioHotstar. The feature reflects the strong internal traction of its clinical practices
driven by consistent outcomes, multidisciplinary collaboration, and protocol led care, while
highlighting how the OncoSciences team’s patient first approach and integrated efforts are now set
to take its achievements onto a global platform through this episode.

The docuseries brings together compelling narratives at the intersection of science, innovation, and
patient care, spotlighting medical institutions and caregivers driving meaningful transformation in
healthcare. As part of a four episode Season 2 lineup, Fortis Cancer Institute’s feature will highlight
its integrated oncosciences ecosystem, clinical excellence, and patient centric pathways that are
redefining cancer care delivery in India, poising for greater global visibility through this recognition.
The feature captures the journeys of two cancer warriors one treated for Breast Cancer (stage 4)
and the other for Blood Cancer (Leukemia) highlighting how the patients, along with the dedicated
team at the Fortis Cancer Institute, navigated their treatment journeys with resilience and emerged
cancer free, returning to their families with renewed health and hope.

Speaking about the feature, Dr. Vishal Beri, Facility Director, Fortis Hospital Mulund, Mumbai said,
“Being featured on Molecules of Hope is a significant milestone for us. It showcases how innovation,
clinical expertise, and compassionate care come together to transform cancer outcomes. At Fortis
Mulund, we are committed to not just treating cancer but changing the way it is perceived by
encouraging early detection, reducing stigma, and making advanced care more accessible because
today, hope really has a new story to tell.”

India is expected to see a sharp rise in cancer cases over the next two decades, with annual new
diagnoses projected to increase from around 1.5 million to nearly 2.5 million by 2045. The Indian
Cancer Society (ICS) has cautioned that this growing burden makes it essential to prioritise early
detection and prevention, alongside strengthening treatment infrastructure, to effectively address
the future cancer challenge.

With cancer awareness days such as head & neck cancer, esophageal cancer, testicular cancer,
observed in April, this feature comes at a critical time to drive conversations around early detection
and timely intervention. Fortis Hospital Mulund’s Fortis Cancer Institute aims to leverage this
platform to further engage the community, healthcare professionals, and stakeholders in building a
more informed and proactive approach to cancer care.

Dr. S Narayani, Business Head  Fortis Hospitals,
Maharashtra, said “The future of cancer care in India will be defined by how effectively we integrate
innovation with accessibility. Platforms like ‘Molecules of Hope’ help bring this narrative to the
forefront. At Fortis, we see ourselves contributing to this next phase by building comprehensive
oncology models that prioritise early detection, precision led treatment, and continuity of care. Our
endeavour is to not only deliver clinical outcomes, but to help shape a more progressive and patient
centric cancer care ecosystem in the country. From Mumbai, we are proud to contribute to a larger
narrative on how cancer care in India is evolving and how institutions like ours can help shape wider
conversations around the future of OncoSciences.”

As part of this initiative, Fortis will roll out a series of engagement led activities including community
awareness programs, community screening initiatives (which have already reached 1lac households),
collaborations with general practitioners, and knowledge sharing platforms to extend the impact of
this feature beyond the screen.